New antidepressant drug increases ‘brain’s own cannabis’

Posted on December 14, 2005 

New antidepressant drug increases ‘brain’s own cannabis’

Researchers have discovered a new drug that raises the level of endocannabinoids–the ‘brain’s own cannabis’–providing anti-depressant effects. The new research published in this week’s Proceedings of the National Academy of Sciences (PNAS), suggests the new drug, called URB597, could represent a safer alternative to cannabis for the treatment of pain and depression, and open the door to new and improved treatments for clinical depression–a condition that affects around 20% of Canadians.

Comments

Leave a Reply